Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells-Reference-Cited by-同舟云学术

Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells

Published:2016-05-06 Issue:5 Volume:5 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Chao Ting‐Hsing¹,Chen I‐Chih²,Li Yi‐Heng¹,Lee Po‐Tseng¹,Tseng Shih‐Ya³

Affiliation:

1. Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan

2. Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan

3. Department of Biological Science, National Sun Yat‐Sen University, Kaohsiung, Taiwan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference52 articles.

1. Vascular Dysfunction and Reduced Circulating Endothelial Progenitor Cells in Young Healthy UK South Asian Men

2. Cilostazol enhances mobilization of circulating endothelial progenitor cells and improves endothelium‐dependent function in patients at high risk of cardiovascular disease;Chao TH;Angiology

3. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control

4. Effects of oxidative stress on endothelial function after a high-fat meal

5. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of lipids and lipid-lowering drugs with peripheral arterial disease: A Mendelian randomization study;Journal of Clinical Lipidology;2024-07

2. Association of proprotein convertase subtilisin/kexin type 9 protein and oxidative stress indicators in women with preeclampsia: A case-control study;International Journal of Reproductive BioMedicine (IJRM);2023-11-21

3. Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Associated with Disease Activity and Risk of Incident Cardiovascular Disease in Patients with Systemic Lupus Erythematosus;Inflammation;2023-05-06

4. Diverse Effects of Cilostazol on Proprotein Convertase Subtilisin/Kexin Type 9 between Obesity and Non-Obesity;International Journal of Molecular Sciences;2022-08-29

5. Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units;Biomedicines;2022-07-15